Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatology Wiley

Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

Loading next page...
 
/lp/wiley/interferon-release-assay-versus-tuberculin-skin-test-prior-to-GdBAUtg0rH

References (42)

Publisher
Wiley
Copyright
Copyright © 2012 Wiley Subscription Services, Inc., A Wiley Company
ISSN
2326-5191
eISSN
2326-5205
DOI
10.1002/art.34382
Publisher site
See Article on Publisher Site

Abstract

Journal

Arthritis & RheumatologyWiley

Published: Jul 1, 2012

There are no references for this article.